Hanna Sallinen

Kuopio, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Proteogenomic approach to immunopeptidomics of ovarian tumors identifies shared peptide vaccine candidates.

Proteogenomic approach to immunopeptidomics of ovarian tumors identifies shared peptide vaccine candidates.

Journal: NPJ vaccines
Published: March 06, 2025

Dynamic contrast-enhanced MRI to characterize angiogenesis in primary epithelial ovarian cancer: An exploratory study.

Dynamic contrast-enhanced MRI to characterize angiogenesis in primary epithelial ovarian cancer: An exploratory study.

Journal: European journal of radiology
Published: January 06, 2023

AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined with chemotherapy reduces the growth and microvasculature of human ovarian cancer and prolongs the survival in mice.

AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined with chemotherapy reduces the growth and microvasculature of human ovarian cancer and prolongs the survival in mice.

Journal: Frontiers in medicine
Published: August 12, 2022

Neoadjuvant chemotherapy induces an elevation of tumour apparent diffusion coefficient values in patients with ovarian cancer.

Neoadjuvant chemotherapy induces an elevation of tumour apparent diffusion coefficient values in patients with ovarian cancer.

Journal: BMC cancer
Published: May 30, 2022

Robotic-assisted laparoscopy is a feasible method for resection of deep infiltrating endometriosis, especially in the rectosigmoid area.

Robotic-assisted laparoscopy is a feasible method for resection of deep infiltrating endometriosis, especially in the rectosigmoid area.

Journal: The Journal of international medical research
Published: August 19, 2021

Microvessels in Epithelial Ovarian Tumors: High Microvessel Density Is a Significant Feature of Malignant Ovarian Tumors.

Microvessels in Epithelial Ovarian Tumors: High Microvessel Density Is a Significant Feature of Malignant Ovarian Tumors.

Journal: Anticancer research
Published: October 07, 2020

High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer.

High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer.

Journal: PloS one
Published: December 01, 2019

Comparative transcriptome analysis of matched primary and distant metastatic ovarian carcinoma.

Comparative transcriptome analysis of matched primary and distant metastatic ovarian carcinoma.

Journal: BMC cancer
Published: May 14, 2019

Dynamic contrast-enhanced perfusion parameters in ovarian cancer: Good accuracy in identifying high HIF-1α expression.

Dynamic contrast-enhanced perfusion parameters in ovarian cancer: Good accuracy in identifying high HIF-1α expression.

Journal: PloS one
Published: April 26, 2019

Prognostic value of preoperative dynamic contrast-enhanced magnetic resonance imaging in epithelial ovarian cancer.

Prognostic value of preoperative dynamic contrast-enhanced magnetic resonance imaging in epithelial ovarian cancer.

Journal: European journal of radiology
Published: January 04, 2019

Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.

Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.

Journal: BMC cancer
Published: October 08, 2018

Combined Gene Therapy Using AdsVEGFR2 and AdsTie2 With Chemotherapy Reduces the Growth of Human Ovarian Cancer and Formation of Ascites in Mice.

Combined Gene Therapy Using AdsVEGFR2 and AdsTie2 With Chemotherapy Reduces the Growth of Human Ovarian Cancer and Formation of Ascites in Mice.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 13, 2017
Showing 1-12 of 15

Last Updated: 09/26/2026